A detailed history of Ramiah Investment Group transactions in Incyte Corp stock. As of the latest transaction made, Ramiah Investment Group holds 11,153 shares of INCY stock, worth $826,771. This represents 2.68% of its overall portfolio holdings.

Number of Shares
11,153
Previous 10,394 7.3%
Holding current value
$826,771
Previous $693 Million 29.33%
% of portfolio
2.68%
Previous 2.22%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2025

BUY
$67.18 - $84.11 $50,989 - $63,839
759 Added 7.3%
11,153 $896 Million
Q3 2022

Feb 10, 2025

BUY
$66.18 - $82.86 $687,874 - $861,246
10,394 New
10,394 $693 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Ramiah Investment Group Portfolio

Follow Ramiah Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ramiah Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Ramiah Investment Group with notifications on news.